Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast
Public ClinicalTrials.gov record NCT02749370. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed Therapy With Apremilast
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy of etanercept in adults with moderate to severe plaque psoriasis who have failed therapy with apremilast (Otezla).
Study identification
- NCT ID
- NCT02749370
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 18, 2016 (Actual)
- Primary completion
- Aug 14, 2017 (Actual)
- Completion
- Dec 6, 2017 (Actual)
- Last update posted
- May 13, 2020
2016 – 2017
United States locations
- U.S. sites
- 22
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Scottsdale | Arizona | 85254 | — |
| Research Site | Beverly Hills | California | 90211 | — |
| Research Site | Fountain Valley | California | 92708 | — |
| Research Site | Newport Beach | California | 92663 | — |
| Research Site | San Ramon | California | 94583 | — |
| Research Site | Santa Monica | California | 90404 | — |
| Research Site | Coral Gables | Florida | 33134 | — |
| Research Site | Jacksonville | Florida | 32204 | — |
| Research Site | Macon | Georgia | 31217 | — |
| Research Site | Louisville | Kentucky | 40217 | — |
| Research Site | Rockville | Maryland | 20850 | — |
| Research Site | Ann Arbor | Michigan | 48103 | — |
| Research Site | Clarkston | Michigan | 48346 | — |
| Research Site | Fort Gratiot | Michigan | 48059 | — |
| Research Site | St Louis | Missouri | 63117 | — |
| Research Site | Henderson | Nevada | 89052 | — |
| Research Site | East Windsor | New Jersey | 08520 | — |
| Research Site | Verona | New Jersey | 07044 | — |
| Research Site | New York | New York | 10075 | — |
| Research Site | Greenville | North Carolina | 27834 | — |
| Research Site | Houston | Texas | 77082 | — |
| Research Site | San Antonio | Texas | 78218 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02749370, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2020 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02749370 live on ClinicalTrials.gov.